{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:06:20Z","timestamp":1746331580526,"version":"3.40.4"},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>In axSpA, validated PROs are well-established in clinical trials, but it remains unclear whether they comprehensively reflect patients\u2019 discomfort and disease status. We aimed to investigate how patients\u2019 self-reported disease status compares with validated clinical trial measures during routine clinical visits.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Data from axSpA patients\u2019 initial and last five visits were retrospectively analysed. ASDAS, BASDAI, ASAS20, ASAS40 and ASAS partial remission were assessed at each visit and compared with patients\u2019 self-reported disease status, categorized into very good (status satisfaction), mild, severe and very severe based on patients\u2019 self-reported opinion on the level of severity of symptom burden related to axSpA. The association of these PROs with patients\u2019 self-reported disease status was analysed using mixed models.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 3,120 visits over a median follow-up of 4.7 years from 557 axSpA patients were analyzed. Very good or mild self-reported disease status was reported in 98.7% of visits with inactive and 90.9% of visits with low ASDAS compared to 67.9% with high and 39.3% with very high ASDAS. Severe or very severe self-reported disease status was reported in 15.1% of visits with ASAS20 achievement, in 7.2% with ASAS40 achievement, and in 0.6% with achievement of ASAS partial remission, compared with 26.0% without ASAS20 achievement, 25.1% without ASAS40 achievement, and 30.1% without achievement of ASAS partial remission.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Patients\u2019 self-reported disease status was well captured by ASDAS and BASDAI in most clinical visits. Other investigated measures used in clinical trials failed to capture patients\u2019 self-reported disease status in a large proportion of visits.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keae648","type":"journal-article","created":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T20:34:18Z","timestamp":1733862858000},"page":"2625-2630","source":"Crossref","is-referenced-by-count":0,"title":["Association of validated patient reported outcome measures with patients\u2019 self-reported disease status in axial spondyloarthritis"],"prefix":"10.1093","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3377-2683","authenticated-orcid":false,"given":"Imke","family":"Redeker","sequence":"first","affiliation":[{"name":"Ruhr-Universit\u00e4t Bochum, Germany and Rheumazentrum Ruhrgebiet , Herne,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2624-7485","authenticated-orcid":false,"given":"Styliani","family":"Tsiami","sequence":"additional","affiliation":[{"name":"Ruhr-Universit\u00e4t Bochum, Germany and Rheumazentrum Ruhrgebiet , Herne,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalliopi","family":"Klavdianou","sequence":"additional","affiliation":[{"name":"\u2018Asklepieion\u2019 General Hospital , Voula,","place":["Greece"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaren Elif","family":"Oezdemir","sequence":"additional","affiliation":[{"name":"Ruhr-Universit\u00e4t Bochum, Germany and Rheumazentrum Ruhrgebiet , Herne,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Sewerin","sequence":"additional","affiliation":[{"name":"Ruhr-Universit\u00e4t Bochum, Germany and Rheumazentrum Ruhrgebiet , Herne,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1602-7649","authenticated-orcid":false,"given":"David","family":"Kiefer","sequence":"additional","affiliation":[{"name":"Ruhr-Universit\u00e4t Bochum, Germany and Rheumazentrum Ruhrgebiet , Herne,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8007-9905","authenticated-orcid":false,"given":"Ioana","family":"Andreica","sequence":"additional","affiliation":[{"name":"Ruhr-Universit\u00e4t Bochum, Germany and Rheumazentrum Ruhrgebiet , Herne,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Kernder","sequence":"additional","affiliation":[{"name":"Ruhr-Universit\u00e4t Bochum, Germany and Rheumazentrum Ruhrgebiet , Herne,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Vossen","sequence":"additional","affiliation":[{"name":"Ruhr-Universit\u00e4t Bochum, Germany and Rheumazentrum Ruhrgebiet , Herne,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5668-4497","authenticated-orcid":false,"given":"Uta","family":"Kiltz","sequence":"additional","affiliation":[{"name":"Ruhr-Universit\u00e4t Bochum, Germany and Rheumazentrum Ruhrgebiet , Herne,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9475-9362","authenticated-orcid":false,"given":"Xenofon","family":"Baraliakos","sequence":"additional","affiliation":[{"name":"Ruhr-Universit\u00e4t Bochum, Germany and Rheumazentrum Ruhrgebiet , Herne,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,12,5]]},"reference":[{"key":"2025050316122114300_keae648-B1","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1136\/annrheumdis-2022-222747","article-title":"Instrument selection for the ASAS core outcome set for axial spondyloarthritis","volume":"82","author":"Navarro-Comp\u00e1n","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"2025050316122114300_keae648-B2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/ard-2022-223296","article-title":"ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update","volume":"82","author":"Ramiro","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"2025050316122114300_keae648-B3","first-page":"100706","article-title":"Differences and similarities between the EULAR\/ASAS-EULAR and national recommendations for treatment of patients with psoriatic arthritis and axial spondyloarthritis across Europe","volume":"33","author":"Michelsen","year":"2023","journal-title":"Lancet Reg Health\u2014Eur"},{"key":"2025050316122114300_keae648-B4","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1136\/annrheumdis-2018-213184","article-title":"Ankylosing Spondylitis Disease Activity Score (ASDAS): 2018 update of the nomenclature for disease activity states","volume":"77","author":"Machado","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2025050316122114300_keae648-B5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/ard.2008.094870","article-title":"Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis","volume":"68","author":"Lukas","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"2025050316122114300_keae648-B6","first-page":"2286","article-title":"A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index","volume":"21","author":"Garrett","year":"1994","journal-title":"J Rheumatol"},{"key":"2025050316122114300_keae648-B7","first-page":"2281","article-title":"A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index","volume":"21","author":"Calin","year":"1994","journal-title":"J Rheumatol"},{"key":"2025050316122114300_keae648-B8","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1002\/1529-0131(200108)44:8<1876::AID-ART326>3.0.CO;2-F","article-title":"Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis","volume":"44","author":"Anderson","year":"2001","journal-title":"Arthritis Rheum"},{"key":"2025050316122114300_keae648-B9","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1136\/ard.2003.016717","article-title":"Development and preselection of criteria for short term improvement after anti-TNF alpha treatment in ankylosing spondylitis","volume":"63","author":"Brandt","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"2025050316122114300_keae648-B10","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s40744-019-0165-3","article-title":"Translating improvements with ixekizumab in clinical trial outcomes into clinical practice: ASAS40, pain, fatigue, and sleep in ankylosing spondylitis","volume":"6","author":"Mease","year":"2019","journal-title":"Rheumatol Ther"},{"key":"2025050316122114300_keae648-B11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/annrheumdis-2017-211734","article-title":"Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force","volume":"77","author":"Smolen","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2025050316122114300_keae648-B12","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1007\/s11606-011-1655-3","article-title":"Determining Whether a Patient is Feeling Better: pitfalls from the Science of Human Perception","volume":"26","author":"Redelmeier","year":"2011","journal-title":"J Gen Intern Med"},{"key":"2025050316122114300_keae648-B13","doi-asserted-by":"crossref","first-page":"934","DOI":"10.2340\/00015555-2707","article-title":"Alexithymia, illness perception and self-management competency in psoriasis","volume":"97","author":"Larsen","year":"2017","journal-title":"Acta Derm Venereol"},{"key":"2025050316122114300_keae648-B14","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/1756-185X.14704","article-title":"The influence of alexithymia on disease activity and quality of life in patients with axial spondyloarthritis: a cross-sectional study","volume":"26","author":"Cengiz","year":"2023","journal-title":"Int J Rheum Dis"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keae648\/61187553\/keae648.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/5\/2625\/61187553\/keae648.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/5\/2625\/61187553\/keae648.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T20:12:31Z","timestamp":1746303151000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/5\/2625\/7917340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,5]]},"references-count":14,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,12,5]]},"published-print":{"date-parts":[[2025,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keae648","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"type":"print","value":"1462-0324"},{"type":"electronic","value":"1462-0332"}],"subject":[],"published-other":{"date-parts":[[2025,5]]},"published":{"date-parts":[[2024,12,5]]}}}